Inscripciones abiertas IV Curso @filialendouro@Urolchi - Innovación y Tecnología en Endourología
🗓9 septiembre 2022📍Hotel Plaza El Bosque 🇨🇱
✈️ sorteo 2 becas VI Curso Internacional de Endourología y Litiasis @HAlemanBsAs
https://t.co/HHiqWyE69y
Neoadjuvant Systemic Therapy in Kidney and Bladder Cancer: Current Evidence and Emerging Paradigms | American Society of Clinical Oncology Educational Book https://t.co/IonDDpTUJe
KEYNOTE-B15/EV-304 trial is practice-changing: periop EV+ pem:
🔥 47% reduction in risk of events (HR 0.53)
🔥 Significant OS benefit (HR 0.65)
🔥 pCR 55.8% vs 32.5%
A true paradigm shift for cisplatin-eligible MIBC.
Honored to be part of this milestone with our HCSC team #GU26
🧬 Preventing #ProstateCancer Progression During Active Surveillance 🧬
This systematic review/meta-analysis highlights the potential of nonsurgical interventions for prostate cancer patients on Active Surveillance:
5-alpha-reductase inhibitors (5-ARIs) ↓ risk of progression by 41%, without increasing treatment-related adverse events (TRAEs).
Mixed results for other therapies:
Effective: chlormadinone, FT inhibitors, enzalutamide, but with high TRAE rates ⚠️.
Limited benefit from lifestyle/diet interventions.
🔎 Challenges: Variability in biopsy protocols and PSA monitoring may skew findings.
Takeaway: Personalized strategies are crucial to optimize AS outcomes while minimizing risks.
Read Now > https://t.co/qQRU0yamsL @DrShariat@dr_rajwa
The fastest fertility collapse in the world
In 2024 Chile recorded a fertility rate of just 0.88 births per woman, a drop of 23% in a year and 51% since 2015. No country has seen fertility fall as fast.
A look at how social changes have overwhelmed 🇨🇱 and threaten its future.
🧵!
Athletic Club homenajeó a Miguel Ocio, hincha del club que falleció luego de haberse descompensado en la cancha en la SF de la Copa del Rey. Su familia colocó un ramo de flores en su localidad. Hacía 42 años que era socio.